Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bone Biologics (BBLG) Accumulated Depreciation & Amortization (2016 - 2017)

Bone Biologics (BBLG) has disclosed Accumulated Depreciation & Amortization for 2 consecutive years, with $333.0 as the latest value for Q3 2017.

  • On a quarterly basis, Accumulated Depreciation & Amortization rose 50.68% to $333.0 in Q3 2017 year-over-year; TTM through Sep 2017 was $333.0, a 50.68% increase, with the full-year FY2016 number at $261.0, changed N/A from a year prior.
  • Accumulated Depreciation & Amortization was $333.0 for Q3 2017 at Bone Biologics, up from $309.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $333.0 in Q3 2017 to a low of $141.0 in Q1 2016.